Compare ATOS & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATOS | PRT |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 27.0M |
| IPO Year | 2010 | N/A |
| Metric | ATOS | PRT |
|---|---|---|
| Price | $2.40 | $2.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 54.9K | 22.9K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 13.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,758.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $1.82 |
| 52 Week High | $7.56 | $4.01 |
| Indicator | ATOS | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 42.02 |
| Support Level | $2.32 | $2.02 |
| Resistance Level | $2.60 | $2.32 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 34.73 | 10.00 |
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.